Levodopa-Induced Dyskinesias in Parkinson’s Disease: An Overview on Pathophysiology, Clinical Manifestations, Therapy Management Strategies and Future Directions

Since its first introduction, levodopa has become the cornerstone for the treatment of Parkinson’s disease and remains the leading therapeutic choice for motor control therapy so far. Unfortunately, the subsequent appearance of abnormal involuntary movements, known as dyskinesias, is a frequent draw...

Descripción completa

Detalles Bibliográficos
Autores principales: di Biase, Lazzaro, Pecoraro, Pasquale Maria, Carbone, Simona Paola, Caminiti, Maria Letizia, Di Lazzaro, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342913/
https://www.ncbi.nlm.nih.gov/pubmed/37445461
http://dx.doi.org/10.3390/jcm12134427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342913/
https://www.ncbi.nlm.nih.gov/pubmed/37445461
http://dx.doi.org/10.3390/jcm12134427

Ejemplares similares